Open access
Jul 2026
Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas
The tolerability and efficacy of berubicin, including one durable complete response, warrant continued development of the molecule.
C. Conrad, S. Hsu, N. Thapar et al.
· Neuro-Oncology Advances · 0 citations